WI
PJP icon

WBI Investments’s Invesco Pharmaceuticals ETF PJP Stock Holding History

WBI Investments’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,068
Closed -$739K – 379
2025
Q4 		$739K Buy
7,068
+1,673
+31% +$168K 0.19% 151
2025
Q3 		$499K Buy
+5,395
New +$472K 0.13% 189

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WBI Investments's PJP Position: Q1 2026 in Review

WBI Investments sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 7,068 shares — an estimated $739K sold.

WBI Investments first reported a position in PJP in Q3 2025 and held it in 2 quarters. The position peaked at $739K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • WBI Investments reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • WBI Investments sold 7,068 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $739K.
  • WBI Investments first reported a position in Invesco Pharmaceuticals ETF in Q3 2025 and held it in 2 quarters.
  • WBI Investments's Invesco Pharmaceuticals ETF position peaked at $739K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.